Queens Medical Center – July 2012

A Queens Medical Center trial found a 15 minute decrease in PACU stay when nauseated patients used QueaseEASE®. There was also a 37% decrease in Phenergan use and more than a 50% decrease of Kytril administration. In addition, 82% of patients felt that QueaseEASE® helped relieve their nausea.

Madigan Healthcare System – December 2012

In a study conducted by Madigan Healthcare System, users of QueaseEASE® , compared to placebo, showed a statistically significant decrease in nausea, as well as a significantly higher perception of treatment effectiveness.

Bon Secour St. Francis Health System – March 2013

Clinical trials conducted at Bon Secour St. Francis Health System concluded that 70% of patients reported relief of nausea after using QueaseEASE®, both in PACU and post-discharge. In addition, 97% were satisfied with their treatment for nausea.

Scripps – March 2013

Scripps Clinic Carmel Valley conducted a small investigational trial that found that 62% of patients got relief from their nausea after inhaling QueaseEASE®. The average patient rating of the product was 4.5 out of 5.

Floyd Memorial Hospital – August 2013

Published in the October 2015 issue of JoPAN, a Floyd Memorial Hospital study showed using QueaseEASE® for post discharge nausea reduced nausea 100% of the time. In addition, nearly half experienced complete relief.

Stephens Memorial Hospital – January 2014

A study conducted at Stephens Memorial Hospital showed that 90% of patients using QueaseEASE® had relief from their nausea, with 50% experiencing complete relief.

St. Jude Children’s Research Hospital – September 2014

At St. Jude Children’s Research Hospital, data collected from a three month pilot project showed QueaseEASE® to be a feasible intervention. It also found that patients, families, and nursing staff were highly satisfied with QueaseEASE®.

University of Colorado – April 2015

In a University of Colorado descriptive qualitative study comparing QueaseEASE® to alcohol pads, patients and nurses both reported significantly higher satisfaction with QueaseEASE®.

Houston Methodist – May 2016

In a study conducted at Houston Methodist Sugarland Hospital, results showed a 60% reduction in antiemetic drug use after patients inhaled QueaseEASE® in the PACU. This led to a 100% recommendation to include it in their multi-modal therapy for PONV.

Deaconess Hospital – March 2017

In a prospective randomized study comparing QueaseEASE® to standard post discharge nausea care, 100% of the patients using QueaseEASE® found effective relief from their PDN.

Oregon Health and Science University – April 2017

Oregon Health and Science University conducted a limited size clinical trial of QueaseEASE® to test efficacy and patient satisfaction. Findings showed 85% of users had total relief of nausea and were satisfied with QueaseEASE®.

UMass Lowell School of Nursing – December 2018

In a randomized study comparing QueaseEASE to conventional medication, PONV relief was achieved within 7.8 minutes for QueaseEASE users compared to 66.8 minutes for patients given anti-emetics.